1. Home
  2. HZO vs SGP Comparison

HZO vs SGP Comparison

Compare HZO & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

HOLD

Current Price

$34.70

Market Cap

769.2M

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$17.87

Market Cap

643.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HZO
SGP
Founded
1998
2019
Country
United States
United States
Employees
N/A
65
Industry
Auto & Home Supply Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
769.2M
643.9M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
HZO
SGP
Price
$34.70
$17.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$30.00
$45.00
AVG Volume (30 Days)
384.6K
48.1K
Earning Date
04-23-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,309,288,000.00
N/A
Revenue This Year
$3.67
N/A
Revenue Next Year
$4.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.39
$18.18
52 Week High
$36.25
$30.56

Technical Indicators

Market Signals
Indicator
HZO
SGP
Relative Strength Index (RSI) 60.95 28.87
Support Level $24.00 N/A
Resistance Level $36.25 $26.29
Average True Range (ATR) 1.46 1.57
MACD -0.03 -0.41
Stochastic Oscillator 69.49 13.11

Price Performance

Historical Comparison
HZO
SGP

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: